Tominaga hospital

本机构学者在这里署名、按本站篇数

合作机构同一篇文章里的其他机构

1. Fujitsu (Japan)日本2
2. Saitama Neuropsychiatric Institute日本1
3. Otsuka (Japan)日本1
4. Shonan Keiiku Hospital日本1
5. Dokkyo Medical University日本1
6. Eli Lilly (Japan)日本1
7. Dokkyo Medical University Hospital日本1
8. Shizuoka Red Cross Hospital日本1

按月发文

逐年被引

最新文献

1. 1
   A multicenter, open-label, phase 3 study to evaluate the safety of fremanezumab for migraine, subcutaneously self-administered with an auto-injection device at institutional sites and at homeExpert Opinion on Drug Safety20222
2. 2
   A long-term open-label safety study of galcanezumab in Japanese patients with migraineExpert Opinion on Drug Safety202128

高被引文献

1. 1
   A long-term open-label safety study of galcanezumab in Japanese patients with migraineExpert Opinion on Drug Safety202128
2. 2
   A multicenter, open-label, phase 3 study to evaluate the safety of fremanezumab for migraine, subcutaneously self-administered with an auto-injection device at institutional sites and at homeExpert Opinion on Drug Safety20222

主要发表期刊